Pathological roles of invadopodia in cancer invasion and metastasis

Alexander, 2008, Extracellular matrix rigidity promotes invadopodia activity, Curr. Biol., 18, 1295, 10.1016/j.cub.2008.07.090

Ammer, 2009, Saracatinib impairs head and neck squamous cell carcinoma invasion by disrupting invadopodia function, J. Cancer Sci. Ther., 1, 52, 10.4172/1948-5956.1000009

Artym, 2011, Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes, Eur. J. Cell Biol., 90, 172, 10.1016/j.ejcb.2010.06.006

Attanasio, 2011, Novel invadopodia components revealed by differential proteomic analysis, Eur. J. Cell Biol., 90, 115, 10.1016/j.ejcb.2010.05.004

Ayala, 2008, Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation, J. Cell Sci., 121, 369, 10.1242/jcs.008037

Ayala, 2009, Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer, Cancer Res., 69, 747, 10.1158/0008-5472.CAN-08-1980

Baldassarre, 2003, Dynamin participates in focal extracellular matrix degradation by invasive cells, Mol. Biol. Cell, 14, 1074, 10.1091/mbc.e02-05-0308

Bourguignon, 1998, CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells, J. Cell. Physiol., 176, 206, 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3

Bowden, 1999, An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation, Oncogene, 18, 4440, 10.1038/sj.onc.1202827

Bowden, 2006, Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells, Exp. Cell Res., 312, 1240, 10.1016/j.yexcr.2005.12.012

Buday, 2007, Roles of cortactin in tumor pathogenesis, Biochim. Biophys. Acta, 1775, 263

Burgermeister, 2008, Caveats of caveolin-1 in cancer progression, Cancer Lett., 268, 187, 10.1016/j.canlet.2008.03.055

Caldieri, 2009, Invadopodia biogenesis is regulated by caveolin-mediated modulation of membrane cholesterol levels, J. Cell. Mol. Med., 13, 1728, 10.1111/j.1582-4934.2008.00568.x

Calle, 2006, The leukocyte podosome, Eur. J. Cell Biol., 85, 151, 10.1016/j.ejcb.2005.09.003

Chen, 2010, Migrastatin analogues target fascin to block tumour metastasis, Nature, 464, 1062, 10.1038/nature08978

Chen, 1989, Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells, J. Exp. Zool., 251, 167, 10.1002/jez.1402510206

Chen, 1999, Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization, Ann. N.Y. Acad. Sci., 878, 361, 10.1111/j.1749-6632.1999.tb07695.x

Chiang, 2008, Molecular basis of metastasis, N. Engl. J. Med., 359, 2814, 10.1056/NEJMra0805239

Clark, 2007, Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia, Cancer Res., 67, 4227, 10.1158/0008-5472.CAN-06-3928

Coopman, 1998, Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity, Clin. Cancer Res., 4, 507

Destaing, 2011, Invadosome regulation by adhesion signaling, Curr. Opin. Cell Biol., 23, 597, 10.1016/j.ceb.2011.04.002

Diaz, 2012, Redox signaling at invasive microdomains in cancer cells, Free Radic. Biol. Med., 52, 247, 10.1016/j.freeradbiomed.2011.09.016

Eckert, 2011, Twist1-induced invadopodia formation promotes tumor metastasis, Cancer Cell, 19, 372, 10.1016/j.ccr.2011.01.036

Friedl, 2011, Cancer invasion and the microenvironment: plasticity and reciprocity, Cell, 147, 992, 10.1016/j.cell.2011.11.016

Gaggioli, 2007, Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells, Nat. Cell Biol., 9, 1392, 10.1038/ncb1658

Gligorijevic, 2012, N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors, J. Cell Sci., 125, 724, 10.1242/jcs.092726

Goetz, 2008, Caveolin-1 in tumor progression: the good, the bad and the ugly, Cancer Metastasis Rev., 27, 715, 10.1007/s10555-008-9160-9

Hashimoto, 2004, Requirement for Arf6 in breast cancer invasive activities, Proc. Natl. Acad. Sci. U. S. A., 101, 6647, 10.1073/pnas.0401753101

Jayne, 2007, Molecular biology of peritoneal carcinomatosis, Cancer Treat. Res., 134, 21

Jurdic, 2006, Podosome and sealing zone: specificity of the osteoclast model, Eur. J. Cell Biol., 85, 195, 10.1016/j.ejcb.2005.09.008

Kessenbrock, 2010, Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, 141, 52, 10.1016/j.cell.2010.03.015

Lecomte, 2011, Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin, Proc. Natl. Acad. Sci. U. S. A., 108, 15074, 10.1073/pnas.1015247108

Li, 2010, The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion, Curr. Biol., 20, 339, 10.1016/j.cub.2009.12.035

Li, 2006, PIK3CA mutations in breast cancer are associated with poor outcome, Breast Cancer Res. Treat., 96, 91, 10.1007/s10549-005-9048-0

Linder, 2011, Degrading devices: invadosomes in proteolytic cell invasion, Annu. Rev. Cell Dev. Biol., 27, 185, 10.1146/annurev-cellbio-092910-154216

Liu, 2009, The role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation, Mol. Biol. Cell, 20, 3763, 10.1091/mbc.e08-09-0967

Lizarraga, 2009, Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells, Cancer Res., 69, 2792, 10.1158/0008-5472.CAN-08-3709

Lorenz, 2004, Imaging sites of N-wasp activity in lamellipodia and invadopodia of carcinoma cells, Curr. Biol., 14, 697, 10.1016/j.cub.2004.04.008

Lu, 2010, Intraperitoneal therapy for peritoneal cancer, Future Oncol., 6, 1625, 10.2217/fon.10.100

Machesky, 2010, Fascin: invasive filopodia promoting metastasis, Commun. Integr. Biol., 3, 263, 10.4161/cib.3.3.11556

Mader, 2011, An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion, Cancer Res., 71, 1730, 10.1158/0008-5472.CAN-10-1432

Madsen, 2010, Cancer dissemination – lessons from leukocytes, Dev. Cell, 19, 13, 10.1016/j.devcel.2010.06.013

Magalhaes, 2011, Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway, J. Cell Biol., 195, 903, 10.1083/jcb.201103045

Mandal, 2008, TGF-beta induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways, Exp. Cell Res., 314, 3478, 10.1016/j.yexcr.2008.09.013

Maruyama, 2007, Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women, Clin. Cancer Res., 13, 408, 10.1158/1078-0432.CCR-06-0267

Morishige, 2008, GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion, Nat. Cell Biol., 10, 85, 10.1038/ncb1672

Mueller, 1991, Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia, J. Cell Sci., 99, 213, 10.1242/jcs.99.2.213

Mueller, 1999, A novel protease-docking function of integrin at invadopodia, J. Biol. Chem., 274, 24947, 10.1074/jbc.274.35.24947

Mueller, 1992, Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells, J. Cell Biol., 119, 1309, 10.1083/jcb.119.5.1309

Muralidharan-Chari, 2009, ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo, Cancer Res., 69, 2201, 10.1158/0008-5472.CAN-08-1301

Murphy, 2011, The ‘ins’ and ‘outs’ of podosomes and invadopodia: characteristics, formation and function, Nat. Rev. Mol. Cell Biol., 12, 413, 10.1038/nrm3141

Nakae, 2000, Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp MK929-43F1. Taxonomy, fermentation, isolation and biological activities, J. Antibiot. (Tokyo), 53, 1130, 10.7164/antibiotics.53.1130

Nakahara, 1997, Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion, Proc. Natl. Acad. Sci. U. S. A., 94, 7959, 10.1073/pnas.94.15.7959

Nakahara, 1998, Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia, J. Biol. Chem., 273, 9, 10.1074/jbc.273.1.9

Nakahara, 1996, A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides, J. Biol. Chem., 271, 27221, 10.1074/jbc.271.44.27221

Nakahara, 2003, Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells, Genes Cells, 8, 1019, 10.1111/j.1365-2443.2003.00695.x

Nurnberg, 2011, Nucleating actin for invasion, Nat. Rev. Cancer, 11, 177, 10.1038/nrc3003

Oser, 2011, Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes, Eur. J. Cell Biol., 90, 181, 10.1016/j.ejcb.2010.08.006

Parekh, 2011, Sensing and modulation of invadopodia across a wide range of rigidities, Biophys. J., 100, 573, 10.1016/j.bpj.2010.12.3733

Philippar, 2008, A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis, Dev. Cell, 15, 813, 10.1016/j.devcel.2008.09.003

Pichot, 2009, Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells, Br. J. Cancer, 101, 38, 10.1038/sj.bjc.6605101

Quintavalle, 2011, A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion, Sci. Signal., 4, ra49, 10.1126/scisignal.2002032

Rajadurai, 2012, Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia, J. Cell Sci., 10.1242/jcs.100834

Roussos, 2010, Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors, Breast Cancer Res., 12, R101, 10.1186/bcr2784

Roussos, 2011, Chemotaxis in cancer, Nat. Rev. Cancer, 11, 573, 10.1038/nrc3078

Saal, 2005, PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma, Cancer Res., 65, 2554, 10.1158/0008-5472-CAN-04-3913

Sabeh, 2009, Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited, J. Cell Biol., 185, 11, 10.1083/jcb.200807195

Sakurai-Yageta, 2008, The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA, J. Cell Biol., 181, 985, 10.1083/jcb.200709076

Sarmiento, 2008, WASP family members and formin proteins coordinate regulation of cell protrusions in carcinoma cells, J. Cell Biol., 180, 1245, 10.1083/jcb.200708123

Schmidt-Kittler, 2010, PI3Kalpha inhibitors that inhibit metastasis, Oncotarget, 1, 339, 10.18632/oncotarget.166

Schoumacher, 2010, Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia, J. Cell Biol., 189, 541, 10.1083/jcb.200909113

Scott, 2012, Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis, PLoS One, 7, e29761, 10.1371/journal.pone.0029761

Scott, 2010, LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells, J. Cell Biol., 191, 169, 10.1083/jcb.201002041

Seals, 2005, The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells, Cancer Cell, 7, 155, 10.1016/j.ccr.2005.01.006

Seiki, 2003, Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion, Cancer Lett., 194, 1, 10.1016/S0304-3835(02)00699-7

Shan, 2005, Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice, Proc. Natl. Acad. Sci. U. S. A., 102, 3772, 10.1073/pnas.0500658102

Smith-Pearson, 2010, Abl kinases are required for invadopodia formation and chemokine-induced invasion, J. Biol. Chem., 285, 40201, 10.1074/jbc.M110.147330

Steffen, 2008, MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7, Curr. Biol., 18, 926, 10.1016/j.cub.2008.05.044

Stylli, 2012, Prognostic significance of Tks5 expression in gliomas, J. Clin. Neurosci., 19, 436, 10.1016/j.jocn.2011.11.013

Stylli, 2008, Invadopodia: at the cutting edge of tumour invasion, J. Clin. Neurosci., 15, 725, 10.1016/j.jocn.2008.03.003

Sutoh, 2010, Invadopodia formation by bladder tumor cells, Oncol. Res., 19, 85, 10.3727/096504010X12875107808008

Tague, 2004, ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway, Proc. Natl. Acad. Sci. U. S. A., 101, 9671, 10.1073/pnas.0403531101

Takkunen, 2010, Podosome-like structures of non-invasive carcinoma cells are replaced in epithelial-mesenchymal transition by actin comet-embedded invadopodia, J. Cell. Mol. Med., 14, 1569, 10.1111/j.1582-4934.2009.00868.x

Talmadge, 2010, AACR centennial series: the biology of cancer metastasis: historical perspective, Cancer Res., 70, 5649, 10.1158/0008-5472.CAN-10-1040

Tan, 2006, Mechanisms of transcoelomic metastasis in ovarian cancer, Lancet Oncol., 7, 925, 10.1016/S1470-2045(06)70939-1

Tolde, 2010, The structure of invadopodia in a complex 3D environment, Eur. J. Cell Biol., 89, 674, 10.1016/j.ejcb.2010.04.003

Valastyan, 2011, Tumor metastasis: molecular insights and evolving paradigms, Cell, 147, 275, 10.1016/j.cell.2011.09.024

Wang, 2006, The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors, J. Cell Biol., 173, 395, 10.1083/jcb.200510115

Weaver, 2008, Cortactin in tumor invasiveness, Cancer Lett., 265, 157, 10.1016/j.canlet.2008.02.066

Wolf, 2009, Mapping proteolytic cancer cell-extracellular matrix interfaces, Clin. Exp. Metastasis, 26, 289, 10.1007/s10585-008-9190-2

Wolf, 2007, Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion, Nat. Cell Biol., 9, 893, 10.1038/ncb1616

Yamaguchi, 2005, Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin, J. Cell Biol., 168, 441, 10.1083/jcb.200407076

Yamaguchi, 2010, Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis, Oncotarget, 1, 320, 10.18632/oncotarget.164

Yamaguchi, 2009, Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells, Cancer Res., 69, 8594, 10.1158/0008-5472.CAN-09-2305

Yamaguchi, 2005, Cell migration in tumors, Curr. Opin. Cell Biol., 17, 559, 10.1016/j.ceb.2005.08.002

Yamaguchi, 2011, Phosphoinositide 3-kinase signaling pathway mediated by p110alpha regulates invadopodia formation, J. Cell Biol., 193, 1275, 10.1083/jcb.201009126

Yamamoto, 2011, Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells, J. Urol., 185, 1930, 10.1016/j.juro.2010.12.027

Yu, 2012, Cells assemble invadopodia-like structures and invade into Matrigel in a matrix metalloprotease dependent manner in the circular invasion assay, PLoS One, 7, e30605, 10.1371/journal.pone.0030605